Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Outcome for Outcome Of Board Meeting

 This is to inform that the Board of Directors of the Company has, at its meeting held on Monday, 8th August, 2022 (i.e. today), inter-alia, considered and approved the following items: 1. Considered and approved the Un-audited Financial Results for the quarter ended 30th June, 2022, along with the Limited Review Report of the statutory auditor. 2. Approved convening the thirty-fourth Annual General Meeting (AGM) of the Company, on Friday, 23rd September, 2022, through video conferencing and other audio visual means. 3. The Register of Members and Share Transfer Books of the Company shall remain closed from Saturday, 17th September, 2022 to Friday, 23rd September, 2022 (both days inclusive) for the purpose of the AGM and declaration of dividend. The Board meeting commenced at 3.00 p.m. and ended at 5.20 p.m.
08-08-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 30Th June, 2022

 INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 ,inter alia, to consider and approve the unaudited financial results for the quarter ended 30th June, 2022
29-07-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Statement Of Investor Complaints For The Quarter Ended June 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 010100 Name of the Signatory :- PRIYA RANJANDesignation :- Company Secretary and Compliance Officer
12-07-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, enclosed please find herewith a Certificate dated 5th July, 2022, issued by M/s. Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company, for the quarter ended 30th June, 2022. This is for your information and record.
11-07-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

 Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st July, 2022 till 48 hours after the declaration of un-audited financial results for the quarter ending 30th June, 2022. The date of the Board Meeting to consider the un-audited financial results for the quarter ending 30th June, 2022, shall be intimated separately.
27-06-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has issued duplicate share certificate in respect of Share Certificates reported to be lost by the shareholder. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificate are as given below: Name of the Shareholder Folio no. No. of shares Old Certificate Nos. Distinctive Nos. New Certificate No. Manish Handa 5242 1000 37714 - 37723 71191201 - 71192200 209385 This is for your information and record
18-06-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has received intimation from a shareholder on 28th May, 2022, regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Certificate Nos. Distinctive Nos. Manish Handa 5242 1000 37714 - 37723 71191201 - 71192200 This is for your information and record.
30-05-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Disclosure Of Related Party Transactions

 Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 31st March, 2022. This is for your information and record.
24-05-2022
Bigul

Annual report for Indraprastha Medical Corporation Ltd. for FY-2022
21-05-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board recommends Dividend

 Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2022, inter alia, has recommended a dividend @25% i.e. Rs. 2.50 per share for the financial year 2021-22.
20-05-2022
Next Page
Close

Let's Open Free Demat Account